completed of $2M USD
“Helping my aging parents from afar was a challenge, as both my parents live on the other side of the country and my mother’s health needs constant monitoring. All of the traditional ways of frequent weekly visits to her doctor and the cumbersome at-home measuring devices were simply not working, not to mention expensive. I made it my mission to create a better solution. Looking at my own experience and the real dynamics of today’s struggles of aging families, we also listened closely to the needs of health care providers. As a result, we created the VoCare Vitals360®. It solves the problem for both patients and providers alike.”
Vitals360® is the world’s first and only professional grade, hand-held, medical device providing a 6-in-1 vitals diagnostic and remote monitoring solution.
Steven R. Peabody
CEO & Chairman
It’s like having a Portable Doctor’s Office in the home that will promote healthier and longer lives, while also significantly lowering costs and reducing the mounting pressure on today’s health care system.
Fast Facts: Vitals360® device
Measures 6 Key Vitals
Blood Oxygen Saturation
ECG Heart Rhythms
Financing for providers for 3 years: $0 device and $49 per month
SIM Card Slot
Video Connect to Conduct Telehealth Visits Right on the Device
Android Operating System
Easy Integration with EMRs and EHRs
Automatically Uploads to the Cloud
I am excited not only by the robust capability but even more so by how easy this product is to deploy. I can literally hand one to a patient in the office and that day they can be transmitting me the things I need to help manage common chronic conditions.
Ben H. Park MD, CEO of American Health Network
Ideal for use by home health care professionals and chronic care management for patients
First and only device that can be used for point-of-care and remote patient monitoring
The Vitals360® is the only multi-diagnostic device that can provide multiple readings as well as provide Wi-Fi and cellular 4G LTE connectivity.
A National Crisis
Baby Boomers Are Aging At An Alarming Rate
baby boomers are aging into Medicare daily
baby boomers will turn 70 years old this year
baby boomers will be older than 50 years old this year
Chronic Illnesses Are At An All Time High
A Broken System of “Invisible Patients”
133 million people in the United States have at least 1 chronic disease - that represents 45% of the American population today.
Patients with chronic illnesses live their lives scheduled around inconvenient and frequent health care appointments. At-home measurement devices currently available in the market are not only cumbersome but cost prohibitive. Given these frustrations, many patients opt-out or skip appointments, leading to greater incidents of fatalities and emergencies.
Today, nearly 5 million homebound individuals are living near the outside edge of the health care system who can not even access care due to physical limitations, chronic illness and/or poverty.
Typically, hospital stays cost $3,250/day for an average stay of 5 days. The average nursing home stay costs $225/day at an average of 825 days per stay. Rehab at home only costs $50/day. Cardiologists and other health care providers are overwhelmed with administrative Medicare and Medicaid submissions, manual reporting errors and mounting pressures including hospital re-admission penalties. Devices in the market today are bulky, unaffordable, and far too complicated for the chronically-ill patient at home needing regular monitoring.
and you’re done!
Vitals360®’s Versatility - 3 Modes
Point of Care Mode
Single Test Mode
Remote Patient Monitoring
Can be used by cardiologists and all other healthcare providers caring for many patients. It replaces multiple medical devices, making it ideal for care both inside and outside a health care facility.
Can be used to spot check patient vital signs, without the need for patient registration. It acts as a convenient multi-diagnostic device.
Can also be used as a daily remote monitoring tool for a single patient. Patients no longer need to keep track of multiple devices. It eliminates the need for cumbersome manual logging of their physiological data.
Vitals360 - for PATIENTS
Care for Seniors
Chronic Care Management
For patients who suffer from diabetes, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), hypertension, and other chronic illnesses.
Patients conveniently taking their own measurements from the comfort of their home will do so more consistently and regularly.
Receiving the results in the device immediately empowers patients to change their behaviour, promoting greater overall health.
Families may also have access to the data, and are reassured that their loved one’s vitals are being automatically sent to their health care provider for review.
Patients can even take the device wherever they may travel.
Patients and their families appreciate the fact that the Vitals360® acts as a security blanket for their loved one.
Today’s aging population is putting growing pressure on health care systems and resources across the country. Being able to monitor seniors while allowing them to continue living in their own homes and lower the need for frequent office visits will greatly improve the value in patient care.
Vitals360® - for PROVIDERS
Safer Post-Discharge Care
Chronic Care Management
Affordable device that provides reliable and relevant patient health information that is actually useful, without the need for separate peripherals or an external hub. The data collected is agnostic and fully customizable to a provider’s choice of software, alleviating information overload.
More and more, hospitals are under pressure to discharge patients quicker, sometimes at the cost of the patient’s health. Being able to monitor and keep track of these patients remotely once they have been discharged will ensure they continue their care plans and reduce chances for readmission – a scenario that is extremely costly to providers.
Being able to monitor patients remotely in between office visits will greatly promote patient autonomy, and alert the care provider when a change in care or intervention is required.
Vitals360® - for other STAKEHOLDERS
Chronically Ill Employees and Worker’s Compensation Cases
Trends Towards Reimbursement for Remote Patient Monitoring (RPM)
Medical Agencies and Payor Companies
Organizations that self-insure medical benefits for their employees are paying millions in medical bills to support chronically ill staff and those who may have been injured on the job. Being able to monitor their employees’ health will keep staff healthier, reduce sick leave, increase productivity and ensure those who are in rehabilitation stick to their care plans and return to work sooner.
The Vitals360®’s GPS location and time-stamping provide a superior audit trail for Medicare reimbursement, while also preventing and providing proof against fraudulent activity. The device’s ability to report measurable outcomes provides useful information for negotiating contracts, attracting more referrals, and adhering to clinical quality measures.
National payer companies like Medicare and Medicaid are changing their approach to encourage more RPM practices to reduce costs and hospital visits. Physicians are now being reimbursed for RPM devices and services so that in-person visits are no longer required. Medicaid pays physicians, RNs (and gradually home health agencies) for delivering care through digital RPM devices such as Vocare’s Vitals360®.
HIPAA Compliant (Health Insurance Portability & Accountability Act)
CTPRB certification on the Qualcomm Gobi Chipset (approved for all carriers)
Currently undergoing final stages seeking FDA-approval
Blood Glucose meter is already FDA approved
Qualcomm Incorporated is a world leader in 3G and next-generation mobile technologies
Size of The Market
Globally, the Home Health market is a $244.4 Billion dollar industry with a rate of growth of 7.8%
Global Health Care Costs are Unsustainable
Rehab services account for 50% of Home Health need globally
Geriatric Population Globally
have Heart Disease, 28M in the USA
Diabetes Globally, 40M in the USA alone
had at least one stroke, 7.4M USA
have Hypertension, 108M in USA
have Chronic Obstructive Pulmonary Disease, 9M USA
have High Cholesterol, 39M USA
There has never been a more critical time for a device like this until now.
We are currently seeking up to $2 million in financing
Final FDA testing
Manufacturing and distributing Vitals360®
Ramp up marketing and sales team
Use of proceeds:
Go to market with Professional Device
Launch Consumer Device in 2020
List on a national exchange
Following this raise we plan to:
At VoCare, our mission as the world’s leading innovator of connected multi-functional diagnostic devices is to seamlessly support providers with actionable patient data in a manner that will increase efficiencies, reduce errors and improve patient care while lowering overall healthcare cost.
Steven R. Peabody CEO & Chairman of VoCare
Massive underserved market
World's first and only patented all-in-one health monitoring solution
Perfectly timed with current trends toward home healthcare
No other similar device that can provide point-of-care benefits
Excellent business model - recurring revenues
Outstanding go-to-market partnerships
Ground floor opportunity to invest
Series A offering in 2010: 10 million raised in debt and equity
New Medicaid reimbursement incentives will no doubt drive even greater sales
$52.5M Projected Revenue, $30M in Earnings
$175M Projected Revenue, $100M in Earnings
The Investment Opportunity
At VoCare, we believe that home healthcare is the future of medicine. Our mission is to improve global health outcomes by providing a clinical grade multi-diagnostic, affordable and connected Medical Device to help reduce healthcare costs across the care continuum. Our purpose built solution can be used as a point of care device for the home health, remote patient monitoring and chronic care markets. We invite you to help us solve the crisis in home health care.
Join us to help millions of patients live longer, healthier lives by becoming an owner in VoCare and launching the Vitals360® device
Projections based on device sales only. There will also be recurring revenues from glucose strips, monthly wireless connectivity and data integration fees, adding significant additional revenue.
In partnership with GEMMS of the Harris Health Care Group, Vocare’s Vitals360® has already secured a 5-year agreement to distribute the device through Harris’ network of providers and hospitals within North America, Europe and Asia. GEMMS, of Harris Computer Systems, a subsidiary of Constellation Software, Inc (CSU, TSE), has already provided millions in in-kind services and direct investment into the development of the device’s software portal and the interoperability of the product. Due to the VoCare and GEMMS partnership, no other product trying to enter this arena could have the same level of financial support, product expertise and knowledge know-how, as the work that has gone into development of the Vitals360® device. Constellation Software has a market cap of $21.5 Billion USD.
VoCare has also secured a partnership with Sinocare, a publicly traded company based in China with offices in the USA. The Vitals360® device will utilize Sinocare’s FDA-approved, high end blood glucose reader and test strips globally. Sinocare has also agreed to distribute the Vitals360® device through their existing global export distribution network in 135 countries worldwide, including the United States. Sinocare has a market cap of $1.5 Billion USD.
Target health professionals and home care agencies eligible for reimbursement by CMS (Centers for Medicare & Medicaid Services) for remote patient monitoring in the home
The business model includes:
a one time charge for the device
recurring revenue for monthly service fee for wireless connectivity
recurring revenue from glucose strips
recurring revenue for monthly data integration fees
Distribution will be processed entirely through the VoCare website, eliminating any expensive retail costs. Initial strategic plan will be focused on targeting health care providers first, and then following with a consumer facing product.
In accordance with the Mercer Capital Medical Device Valuation and Scott Mason M&A Health Care Report for Medical Device Companies valuation methodologies, VoCare's Vitals350 would be valued as a minimum multiple of 15 times EBITDA.
(1 yr post FDA approval, assuming 10k device subscriptions)
= Year 1 Total Valuation:
(assuming 50K device subscriptions)
= Year 2 Total Valuation:
(assuming 100k subscriptions)
= Year 3 Total Valuation:
Product Roadmap & Projected Timeline
What People Are Saying
Vice President Operations - GEMMS, Harris HealthCare
Larry D. Grider
“The partnership between GEMMS of the Harris Healthcare Group and VoCare has been very strong, and we are certainly optimistic about the future together. GEMMS 25 years of expertise in managing and exchanging healthcare data within and across various organizations in order to advance the effective delivery of healthcare and the Harris Healthcare Groups worldwide established markets has been combined with VoCare’s engineering and vision to create a unique RPM tool-one that will undoubtedly revolutionize the health care industry.”
Vice President for Home Services Unlimited
“The VoCare solution's versatility as a point-of-care device or as a remote patient monitoring solution is a disrupting force in the home healthcare market.”
Ph.D., Executive Vice President of GEMMS
Rodger P. Pinto
“The VoCare Vitals360® device along with GEMMS extensive experience in data management and interoperability will allow patient data to be captured easily from anywhere, at any time and sent in real time to providers.”
Medical Doctor and CEO of American Health Network
Ben H. Park MD
“You keep people out of the hospital and out of the emergency room, not by denying things. You do it increasing benefits, removing barriers and giving them better access to care to keep them well in the long-run. The Vitals360 device will play a significant role in achieving this.”
MD, MBA, Chief of Cardiothoracic Surgery, Mercy Health System
Deon W. Vigilance
“Technology is playing a major role in the current medical revolution. Most patients would rather receive their medical care in the privacy of their home, or at a time during the day that is most convenient for their schedule. As a result, patients are more frequently being cared for outside of a tradition medical facility. With that in mind, the Vital360 was designed around a new patient-focused care model. The Vital360 allows for a patient-provider partnership in caring for some of the costliest and most debilitating illness, including congestive heart failure, diabetes, emphysema/COPD, abnormal heart rhythms and hypertension. As the World’s first fully connected 6-in-1 medical device, the Vital360 is essential for remote patient monitoring and delivery of care in a very simple fashion.”
MD, Director of Hepatology, Indiana University School of Medicine
“Vocare’s Vitals 360 is an ideal device for specialists who manage patients with cirrhosis and complex medical needs. It is critical for a team-based health care delivery and would enable us to provide comprehensive and continuous medical care to our patients. It truly embraces the concept of a patient-centered medical home and enhance our ability to obtain maximal health outcomes. This approach is easily scalable to any other disorder with complex medical needs."
Sanford S. Kunkel
“The Vitals 360 from Vocare is a revolutionary device both for monitoring general health conditions and also for post-operative care of patients. This device will allow physicians and physician surgeons to monitor patients and their conditions remotely via telemedicine. This could be a great cost savings to postoperative patients who have the obligation to travel several hours for a short five or 10 minute post-operative visit. The patient’s blood pressure, temperature, blood glucose, body weight and condition of the operative site can all be monitored remotely.
The Neurovascular status and the condition of the patients dressing and real time instructions can be given to patients with the Vitals 360 device. This is a huge complement to today’s precision medicine.”
The beauty of this device is it's intuitive design. The integrated elegance of this platform allows for impressive improvement in healthcare delivery.
Anthony R. Zappia
MD, General Surgery, Lakeland Florida
Board of Directors
Bringing a unique combination of health care and technology, the VoCare team comprises a powerful coalition of executives blending their expertise and successes.
CEO / Chairman of the Board
Steven R. Peabody
A visionary leader, executor, and strategist, with over 17 patents under his name. He has developed products from the idea stage to start up launch and all the way to achieve hyper accelerated growth, generating in excess of $250 million in revenue for multiple Fortune 500 companies.
Deon W. Vigilance, MD, MBA
Cardiothoracic surgeon with an MBA who has received numerous honors and awards in his field. He received his Doctor of Medicine from the Pennsylvania State University and is passionate about medical technology and population health management.
CFO & COO
Successful leader with significant executive experience uniquely specialized in recurring revenue business organizations. He has an extensive background in the cellular industry and has now brought his wealth of knowledge to the integration of wireless technology with the rapid pace of change in the medical monitoring business.
Senior Vice President Strategy
Seasoned executive leader with an extensive background in the communications and IT industries. He has a proven track record ofdriving results and generating revenue by developing and executing effectivego
to market strategies.
Scott R. Storms
Attorney with more than 20 years of experience focusing on corporate, environmental, and energy regulatory matters, with an extensive background in complex regulatory and business matters.
Mary F. Zappia
Well-respected and seasoned attorney with broad experience in litigating business and criminal matters, as well as representing individuals and business in legal and regulatory matters as part of an extensive legal practice.
Orthopedic Surgeon at OrthoIndy
Dr. Sanford Kunkel
A well-respected physician, educator, published author, consultant and independent NFL examiner, Dr. Kunkel has tremendous depth and range of experience in orthopedic surgery, sports medicine, knee reconstruction and shoulder reconstruction. A member of numerous national medical organizations, Dr. Kunkel also served as the team physician for professional sports teams such as the Indiana Pacers and the Indiana Fever, from 1988 through 2006. He also served as the president of the NBA Team Physicians Society.
Members of the Board
President of SAW Capital LLC
Weaver is a venture capitalist with a highly impressive background. He began in tax consulting, and catapulted his career early by helping his firm become one of the largest companies in its field, eventually leading him to become one of the nation’s first non-degreed direct entry partners in a Big 12 accounting firm. Today as a VC, he has founded and sold successful startups and is now president of SAW Capital LLC. SAW’s portfolio companies include VoCare, Grocers Supply Company, GS Transportation LLC, and P2P Solutions, LLC., and numerous similar cutting-edge technology ventures.
Anthony N. Akosa, MD, MBA
As a fully practising physician, Dr. Akosa bring a tremendously valuable viewpoint to the VoCare board by combining his board-certified, family practice viewpoint with his MBA background. Dr. Akosa is directly in touch with the patient experience in healthcare and he oversees corporate medical policy, population health management and practice transformation for HealthEC, serving on the Board 4 of Directors of Population Health Alliance (PHA). He previously served as VP of medical affairs for a provider-owned health plan organization providing managed care solutions.
Global Source One (GSO)
James (Zhibo) Lu
Lu brings many years of experience in product/process development and quality management to VoCare’s Board of Directors. He established Global Source One (GSO), a multinational company that provides supply chain management for companies that need high quality products and competitive production solutions. Lu has also developed a number of qualified suppliers and affiliated factories in China to produce parts for many customers in the North American market, with products ranging from appliances, automotive, drilling, to general industries such as packaging and printing.
CEO/Medical Director of Meridian Health Group
Dr. Gary Wright
Wright brings an extensive medical and entrepreneurial background to VoCare. In addition to his role at Meridian Health Group, Wright is also a Partner with the Indiana Surgery Center. Among other business initiatives, Wright developed a process which ended the outsourcing of physical therapy, instead bringing therapy “in-house”, which resulted in a dramatic increase in revenue. Wright was the principle founder of Summex, Inc., a firm that provided employee population health management services to employers, hospital systems, and managed care organizations. In 2006, Summex was sold to WebMD for over $30,000,000.
The Vocare Team
Disclaimers and Risk Factors for Accredited Investors
This presentation incorporates information from a private placement memorandum and contains forward-looking statements. All statements contained herein other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans, and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in the “Risk Factors” section of the offering circular. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this presentation may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. All references to dollar amounts in the offering summary or to use of proceeds are subject to change pending a final offering.
This investment opportunity is offered under rule 506(c) of Regulation D. As such, purchasers must be accredited investors and the issuer must take reasonable steps to verify their accredited investor status. Therefore, investors must provide verification that they are an accredited investor in order to participate in this offering. Information regarding how to determine and verify accredited investor status, and additional details regarding this offering, is included in VoCare’s Private Placement Memorandum.
Investment in the securities offered hereby involves certain risks and is suitable only for accredited investors of substantial financial means who have no need for initial liquidity in their investments and can bear the risk of loss of their entire investments. Prospective investors should carefully consider the following risk factors in addition to the other information contained in this Memorandum, before making an investment decision concerning VoCare’s common stock. Any of the following risks could materially adversely affect VoCare’s business, financial condition, or operating results and could result in a partial or complete loss of your investment. The risks and uncertainties described below are not, however, the only ones that VoCare may face. Additional risks and uncertainties not currently known to VoCare, or which VoCare currently believes are not material, also could materially adversely affect VoCare’s business, financial condition, or operating results.
RISK FACTORS: THESE SECURITIES INVOLVE A HIGH DEGREE OF RISK AND THEIR PURCHASE SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN AFFORD TO SUSTAIN A TOTAL LOSS OF THEIR INVESTMENT. FOR MORE INFORMATION, PLEASE REFER TO “RISK FACTORS.” THIS CONFIDENTIAL PRIVATE PLACEMENT MEMORANDUM DOES NOT CONSTITUTE AN OFFER OR SOLICITATION IN ANY STATE OR OTHER JURISDICTION WHERE IT WOULD BE UNLAWFUL TO DO SO. NOTICE: THIS PRIVATE PLACEMENT MEMORANDUM AND THE EXHIBITS HERETO (COLLECTIVELY, THE “MEMORANDUM”) DO NOT CONSTITUTE AN OFFER OR SOLICITATION IN ANY STATE OR OTHER JURISDICTION IN WHICH SUCH AN OFFER OR SOLICITATION IS NOT AUTHORIZED.
©2018 VoCare, All Rights Reserved
Invest in VoCare
COPYRIGHT © 2018 Vocare